Seed portfolio

PGTA-ChromInst® Preimplantation Genetic Test-aneuploidy (PGT-A)

Comprehensively identify embryo chromosome aneuploidy to improve the success rate of IVF.

I am a doctor

Why PGTA-ChromInst® Preimplantation Genetic Test-aneuploidy (PGT-A)?


Embryonic chromosomal abnormalities are the main cause for the IVF failure. Advanced maternal age (≥35 years old), recurrent implantation failures, recurrent miscarriages, and severe male infertility, raise the risk of embryo chromosomal abnormalities. PGT-A can select embryos with normal chromosomes for transplantation, thereby increasing the success rate of IVF.


Screen all chromosomes to select healthy embryos for transfer into the mother.


Improve implantation rate, clinical pregnancy rate, sustained pregnancy rate, and live birth rate.


Reduce the number of embryos to transfer

For who?

1 Advanced maternal age

2 Patients with recurrent spontaneous abortion

3 Patients with repeated transplant failure

4 Severe male infertility

Service Process